The milestone payment is reduced to $27 million if premarket approval is received after December 31, 2022. SurModics (SRDX) delivered earnings and revenue surprises of 12.82 and 2.46, respectively, for the quarter ended June 2022.
The potential revenue associated with the $30 million milestone payment would be approximately $25 million. To date, positional cues required for epidermal/mesophyll cell fate. Surmodics has the potential to receive a $30 million milestone payment during fiscal 2022 or fiscal 2023 related to premarket approval of the SurVeil DCB pursuant to the Abbott Development and Distribution Agreement. Expression of ATML1-SRDX, which is supposed to downregulate target genes of ATML1. Sell : 19 927 : Employee Stock Option (right to buy) : Stich Joseph J. Get the latest Surmodics, Inc SRDX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Non-GAAP diluted EPS for fiscal 2022 is expected to range from a loss per share of $(1.23) to $(1.08). Date Person Action Amount type : Stich Joseph J. View Surmodics, Inc SRDX investment & stock information. Surmodics expects fiscal 2022 diluted GAAP EPS, which reflects continued investments to accelerate the Company's strategy, to a range from a loss per share of $(1.50) to $(1.35), from the previous range of $(1.70) to $(1.35). Surmodics Reports Second Quarter Fiscal 2022. What do you think of this SRDX price exceeded its 50-day Moving Average.
#SRDX QTR DATE FULL#
Surmodics expects full year fiscal 2022 revenue to range from $97 million to $99 million, from the previous range of $98 million to $101 million. (SRDX) stock news and headlines to help you in your trading and investing decisions. SRDX Earnings Date 2022 Surmodics Earnings Forecast. The company said, "Surmodics is revising its fiscal year 2022 revenue guidance to reflect expected softness in customer demand and raising its fiscal year 2022 EPS guidance to reflect solid year-to-date results. (NASDAQ:SRDX) shareholders might be concerned after seeing the share price drop 10 in the last quarter. For the next earning release, we expect the company to report earnings of -0.39 per share, reflecting a year-over-year decrease of. SRDX will report 2022 earnings on EPS Estimate 2021 2022 2023 2024 -2.5 0 2.5 Quarterly Numbers Actuals Estimates SRDX will report Q4 2022 earnings on EPS Surprise Estimate. Lowers FY22 revenue view to $97M-$99M from $98M-$101M, consensus $99.76M. Look out for SRDX's next earnings release on July 27, 2022.
0 kommentar(er)
